News
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday.
Hosted on MSN9mon
FDA expands approval of breast cancer drug Kisqali: What to knowThe FDA expanded approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. The decision will free up access to the medication for tens of ...
following the U.S. Food and Drug Administration's expanded approval of the treatment, drug maker Novartis announced Tuesday. "The FDA approval of Kisqali for this early breast cancer population ...
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday.
following the U.S. Food and Drug Administration's expanded approval of the treatment, drug maker Novartis announced Tuesday. “The FDA approval of Kisqali for this early breast cancer population ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback